Skip to main content

Waldron Richard A's Form 4 filing

BioAtla, Inc. (BCAB) · filed Nov 30, 2021

Accession no.
0001209191-21-067221
Filed
Nov 30, 2021
Trade date
Nov 22-24, 2021
Filing delay
8 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $336.9K. It was filed 8 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Waldron Richard ACIK 0001226961Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 22, 2021Common StockSSaleDisposed−3,626$26.24−$95,146.24162,965Direct
Nov 23, 2021Common StockSSaleDisposed−3,669$24.29−$89,120.01159,296Direct
Nov 23, 2021Common StockSSaleDisposed−2,101$26.04−$54,710.04157,195Direct
Nov 24, 2021Common StockSSaleDisposed−1,459$24.05−$35,088.95155,736Direct
Nov 24, 2021Common StockSSaleDisposed−1,354$25.00−$33,850154,382Direct
Nov 24, 2021Common StockSSaleDisposed−1,124$25.77−$28,965.48153,258Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)